Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
B-type natriuretic peptide in the early diagnosis and risk stratification of acute chest pain
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 699773
Author(s) Haaf, Philip; Reichlin, Tobias; Corson, Nils; Twerenbold, Raphael; Reiter, Miriam; Steuer, Stephan; Bassetti, Stefano; Winkler, Katrin; Stelzig, Claudia; Heinisch, Corinna; Drexler, Beatrice; Freidank, Heike; Mueller, Christian
Author(s) at UniBasel Reichlin, Tobias
Bassetti, Stefano
Müller, Christian
Freidank, Heike
Year 2011
Title B-type natriuretic peptide in the early diagnosis and risk stratification of acute chest pain
Journal American Journal of Medicine
Volume 124
Number 5
Pages / Article-Number 444-52
Keywords Acute Coronary Syndrome, Brain Natriuretic Peptide, Chest Pain, Diagnosis, Mortality
Mesh terms Acute Coronary Syndrome, mortality; Aged; Aged, 80 and over; Analysis of Variance; Angina Pectoris, diagnosis; Biomarkers, blood; Chest Pain, etiology; Disease-Free Survival; Early Diagnosis; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction, mortality; Natriuretic Peptide, Brain, blood; Odds Ratio; Predictive Value of Tests; Risk Factors; Troponin T, blood
Abstract Myocardial ischemia is a strong trigger of B-type natriuretic peptide (BNP) release. As ischemia precedes necrosis in acute myocardial infarction, we hypothesized that BNP might be useful in the early diagnosis and risk stratification of patients with acute chest pain.; In a prospective, international multicenter study, BNP was measured in 1075 unselected patients with acute chest pain. The final diagnosis was adjudicated by 2 independent cardiologists. Patients were followed long term regarding mortality.; Acute myocardial infarction was the adjudicated final diagnosis in 168 patients (16%). BNP levels at presentation were significantly higher in acute myocardial infarction as compared with patients with other diagnoses (median 224 pg/mL vs. 56 pg/mL, P >.001). The diagnostic accuracy of BNP for the diagnosis of acute myocardial infarction as quantified by the area under the receiver operating characteristic curve (AUC) (0.74; 95% confidence interval [CI], 0.70-0.78) was lower compared with cardiac troponin T at presentation (AUC 0.88; 95% CI, 0.84-0.92; P >.001). Cumulative 24-month mortality rates were 0.5% in the first, 2.1% in the second, 7.0% in the third, and 22.9% in the fourth quartile of BNP (P >.001). BNP predicted all-cause mortality independently of and more accurately than cardiac troponin T: AUC 0.81 (95% CI, 0.76-0.86) versus AUC 0.70 (95% CI, 0.62-0.77; P >.001). Net reclassification improvement for BNP was 0.10 (P=.04), and integrated discrimination improvement 0.068 (P=.01).; BNP accurately predicts mortality in unselected patients with acute chest pain independently of and more accurately than cardiac troponin T, but does not seem to help in the early diagnosis of acute myocardial infarction.
Publisher Elsevier
ISSN/ISBN 0002-9343 ; 1555-7162
edoc-URL http://edoc.unibas.ch/dok/A5843833
Full Text on edoc No
Digital Object Identifier DOI 10.1016/j.amjmed.2010.11.012
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/21531234
ISI-Number WOS:000290017900016
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.361 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
25/04/2024